Teva Pharmaceutical Industries Ltd. — Board/Management Information 2007

Oct 30, 2007

_________

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.2529Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267297 , 03-9267281 Fax: 03-9267429E.mail address: Liraz.Kalif@Teva.co.ilDate of transmission: 30/10/2007              Time of broadcast: 08:04 08:03:36

Reference: 2007-02-428125

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on TEVA ANNOUNCES PLANNED RETIREMENT OF CFO DAN SUESSKIND IN MID-2008
DanFinal3010071_isa.pdf

Please find attached a press release announced on today in the U.S. and its unofficial hebrew translation. The binding release is the english version.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 05/09/2007
- - -
Name of the Signatory: : Suesskind Dan , , Position of Signatory in the reporting corporation: Chief Financial Officer
Basel Telephone: 02-5892840 , Facsimile: 02-5892839 , E-mail: dan.suesskind@teva.co.il